Moderate Wine Consumption Linked to Reduced Tumor Risk

Researchers found that moderate wine drinkers were as much as 40 percent less likely to develop pituitary adenoma

Moderate Wine Consumption Linked to Reduced Tumor Risk
According to new research, moderate wine consumption is associated with a reduced risk for pituitary tumor development. (Thomas Barwick/Getty)
Jun 7, 2022

The realm of wine and health research entered uncharted territory with a recent paper assessing the association between alcohol consumption and pituitary gland tumors. Analyzing data from three major studies, researchers found a substantial reduction in risk of developing pituitary adenoma among moderate wine drinkers.

Adenomas, which are benign, non-cancerous tumors, can cause headaches, visual impairment and other serious symptoms when their growth puts pressure on nearby nerves beneath the brain. According to the American Cancer Society, more than 10,000 pituitary adenomas are diagnosed each year, and as many as 1 in 4 people may have undiagnosed pituitary tumors.

The paper, published in Cancer Causes & Control and authored by researchers from Harvard University and Brigham and Women's Hospital, was supported by data from three cohort studies: Nurses' Health Study (NHS), Health Professionals Follow-Up Study (HPFS) and Nurses' Health Study II (NHSII). The cohorts totaled 290,000 participants, mostly women, aged 25 to 75, and data was collected every four years starting in 1980 (NHS), 1986 (NHSII) and 1991 (HPFS).

According to co-author Dr. Meir Stampfer, the results showed a 30 to 40 percent reduced risk of pituitary adenoma among moderate wine drinkers (one to two glasses per day) compared to non-drinkers. The same results were not indicated among beer or spirits drinkers.

The authors write that the relationship may be explained by wine’s antioxidant content, and specifically referenced wine’s reputation for promoting vascular health, including “lower risk of cardiovascular disease, diabetes, stroke, kidney cancer, and all-cause mortality.”

However, due to the observational nature of the study, its limited demographic (mostly women already in the healthcare system), the frequency with which pituitary adenoma go undiagnosed, and the lack of pre-existing research, it’s too soon to draw any conclusions. “Nothing in our study should be the cause for any behavior change,” Dr. Stampfer told Wine Spectator. “Mainly, we hope this sheds some light on the causes of this common condition. But wine lovers could take comfort that they are decreasing risk of pituitary adenoma.”


Want to learn more about how wine can be part of a healthy lifestyle? Sign up for Wine Spectator's free Wine & Healthy Living e-mail newsletter and get the latest health news, feel-good recipes, wellness tips and more delivered straight to your inbox every other week!

News brain-health-memory health

You Might Also Like

Möet Hennessy Buys Napa's Joseph Phelps Vineyards

Möet Hennessy Buys Napa's Joseph Phelps Vineyards

The multinational luxury corporation has purchased a Napa icon, home of Insignia

Jun 29, 2022
Cava Bubbles Up

Cava Bubbles Up

Spain's signature sparkling wine has been overshadowed by Champagne and Prosecco, but …

Jun 28, 2022
Wine Spectator Reveals 2022 Restaurant Award Winners

Wine Spectator Reveals 2022 Restaurant Award Winners

Nearly 3,200 restaurants around the world earned honors for their ambitious wine programs, …

Jun 27, 2022
Chateau Ste. Michelle Without the Chateau?

Chateau Ste. Michelle Without the Chateau?

Washington state's biggest winery puts its flagship Woodinville property on the market

Jun 24, 2022
2 Restaurants Win New Grand Awards in 2022

2 Restaurants Win New Grand Awards in 2022

Wine Spectator recognizes dining destinations in New York and Napa Valley with its top …

Jun 23, 2022
Exclusive: Foley Family Wines Buys Napa’s Silverado Vineyards

Exclusive: Foley Family Wines Buys Napa’s Silverado Vineyards

Vintner, finance executive and hockey team owner Bill Foley secures 300 acres of Napa vines …

Jun 21, 2022